NCT04701255

Brief Summary

With the advancement of cataract eye surgery and wavefront sensors, the previously unquantifiable refractive measurements have been identified and the high order aberrations have shown their effect on high resolution imaging. In the human phakic eye, the shape of the normal cornea induces average positive spherical aberration and remains unchanged over time, whereas the crystalline lens has a negative spherical aberration. As a result, overall spherical aberration in the young eye is low. However, the compensation slowly decreases with the aging lens and is fully lost after cataract extraction and implantation of a standard intraocular lens. Optical studies showed that conventional biconvex spherical intraocular lenses add their intrinsic positive spherical aberration to the positive spherical aberration of the cornea resulting in image imperfection and blur. As a useful side effect, this also increases the depth of focus -often referred to as pseudo-accommodation. New Aspheric intraocular lenses designs currently in use impart negative spherical aberration, about 0.17 to 0.20 microns of negative spherical aberration. This added negative spherical aberration partially corrects the average amount of corneal positive spherical aberration \& compensate for its effect. Our study will include (FocusForce foldable aspheric intraocular lens, Bausch \& Lomb, New Jersey, USA) as an example of this type of negative spherical aberration intraocular lenses. In order to improve retinal image quality without compromising depth of field, or introducing other aberrations, aberration-free aspheric intraocular lenses were developed with no inherent spherical aberration. The other intraocular lens targeted in our study (Akreos AO Microincision lens, Bausch \& Lomb, New Jersey, USA) is an example of this type of IOLs.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 9, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 6, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 8, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2021

Completed
Last Updated

January 13, 2021

Status Verified

January 1, 2021

Enrollment Period

8 months

First QC Date

January 6, 2021

Last Update Submit

January 11, 2021

Conditions

Keywords

aberration-freenegative spherical aberrationphacoemulsificationintraocular lenswavefront

Outcome Measures

Primary Outcomes (1)

  • Corneal, Ocular, and Internal spherical aberrations

    assessment of ocular, corneal \& internal wavefront by aberrometer \& corneal tomography

    1 month postoperative

Secondary Outcomes (2)

  • corneal wavefront changes

    1 month postoperative

  • near vision addition

    1 month postoperative

Study Arms (2)

aberration-free IOL

EXPERIMENTAL

20 human eyes with aberration-free intraocular lens Implantation after phacoemulsification cataract surgery

Procedure: phacoemulsification with intraocular lens implantationDevice: ocular aberrometer assesment

negative spherical aberration IOL

ACTIVE COMPARATOR

20 human eyes with negative spherical aberration intraocular lens Implantation after phacoemulsification cataract surgery

Procedure: phacoemulsification with intraocular lens implantationDevice: ocular aberrometer assesment

Interventions

treatment of cataract by phacoemulsification procedure and implantation of different types of IOLs.

aberration-free IOLnegative spherical aberration IOL

evaluate total ocular wavefront, corneal wavefront \& internal wavefront (High order aberrations ) post operative by corneal tomography and aberrometer

aberration-free IOLnegative spherical aberration IOL

Eligibility Criteria

Age21 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients with written informed consent, between the age of 21 -75 years who will undergo phacoemulsification procedure with intraocular lens implantation of one of the targeted lenses in the study

You may not qualify if:

  • Previous corneal intervention or refractive surgery.
  • Persistent Corneal edema (epithelial or stromal).
  • Co-existing corneal pathology.
  • Ocular surface disease \& Dry eye syndrome.
  • Posterior capsular opacity .
  • Anterior capsular contraction (phimosis).
  • Ocular inflammation.
  • Co-existing Vitreoretinal diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

facultyof medicine, Cairo university

Cairo, 12563, Egypt

RECRUITING

MeSH Terms

Conditions

Cataract

Interventions

PhacoemulsificationLens Implantation, Intraocular

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

Cataract ExtractionRefractive Surgical ProceduresOphthalmologic Surgical ProceduresSurgical Procedures, OperativeUltrasonic Surgical Procedures

Study Officials

  • Aya G Ibrahim, MBBCh

    Dar El Oyoun ophthalmology hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mohammed H Hosny, professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 40 human eyes undergoing phacoemulsification with intraocular lens implantation
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident of ophthalmology

Study Record Dates

First Submitted

January 6, 2021

First Posted

January 8, 2021

Study Start

November 9, 2020

Primary Completion

June 30, 2021

Study Completion

June 30, 2021

Last Updated

January 13, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations